ArticleFrontiers in immunology2025

CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis.

Bo Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.